It is generally accepted that there is no residual prostate tissue if serum PSA level reaches nadir levels after radical prostatectomy and that TRT is thought to be safe if symptomatic hypogonadism develops according to the current new data. This evidence concerns the gene KLK3 and hypogonadism.